Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:46 AM
Ignite Modification Date:
2025-12-25 @ 4:46 AM
NCT ID:
NCT00556218
Eligibility Criteria:
Inclusion Criteria:
1. Women with stage I - III breast cancer who have undergone chemotherapy (either neoadjuvant or adjuvant) 6 - 60 months prior to recruitment.
2. Women who report cognitive impairment since starting chemotherapy as assessed by four questions from the FACT-Cog.
3. Women must be 18 years or older.
4. Women must be able to read, write and speak English.
5. Women must be currently undergoing hormone therapy (e.g., Tamoxifen or AIs)
6. Willing to come to MDACC for the meditation sessions and assessment sessions.
7. Women must be within 2 hours driving distance of MDACC.
Exclusion Criteria:
1. Women who have a documented diagnosis of a formal thought disorder (e.g., schizophrenia) will be excluded from the study.
2. Women with metastatic disease to the brain or any past neurologic injury.
3. Women with a Mini-Mental State Examination score of 23 or below.
4. Women with recurrent cancer
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT00556218
Study Brief:
Protocol Section:
NCT00556218